VITAL MEDICINES NOT AVAILABLE: NATIONAL AND INTERNATIONAL REGULATION ANALYSIS, UPDATE PROPOSAL OF NATIONAL LIST

A comparative revision was carried out on the national and international policies and regulations about access of orphan and/or vital drugs.. An analysis of: orphan drugs´ list from USA, European Union and all applications for importation of not available drugs submitted by the Drug Regulatory Autho...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Gloria A. SANDOVAL, Claudia P. VACCA G, Jorge OLARTE
Formato:	article
Lenguaje:	EN
Publicado:	Universidad de Antioquia 2009
Materias:	orphan drugs exceptional drugs rare disease neglected disease legislation Food processing and manufacture TP368-456 Pharmaceutical industry HD9665-9675
Acceso en línea:	https://doaj.org/article/3a565dfc710f46d5a42c3ae53e1fd181
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:3a565dfc710f46d5a42c3ae53e1fd181
record_format	dspace
spelling	oai:doaj.org-article:3a565dfc710f46d5a42c3ae53e1fd1812021-11-19T04:18:48ZVITAL MEDICINES NOT AVAILABLE: NATIONAL AND INTERNATIONAL REGULATION ANALYSIS, UPDATE PROPOSAL OF NATIONAL LIST0121-40042145-2660https://doaj.org/article/3a565dfc710f46d5a42c3ae53e1fd1812009-02-01T00:00:00Zhttps://revistas.udea.edu.co/index.php/vitae/article/view/769https://doaj.org/toc/0121-4004https://doaj.org/toc/2145-2660A comparative revision was carried out on the national and international policies and regulations about access of orphan and/or vital drugs.. An analysis of: orphan drugs´ list from USA, European Union and all applications for importation of not available drugs submitted by the Drug Regulatory Authority (INVIMA) until 2006; an informal consultation with health care providers, insurance companies and distributors of vital medicines, were included, in order to improve the actual vital drugs list within the frame of public health programs. The analysis included all drugs that have been protected by Decree 2085 from 2002, as well as the imported drugs by the Ministry of Social Welfare under the public health program. 26 of 107 proposed drugs match the lists of orphan drugs from the countries analyzed and 12 are protected with exclusivity by decree 2085 from 2002. Gloria A. SANDOVALClaudia P. VACCA GJorge OLARTEUniversidad de Antioquiaarticleorphan drugsexceptional drugsrare diseaseneglected diseaselegislationFood processing and manufactureTP368-456Pharmaceutical industryHD9665-9675ENVitae, Vol 15, Iss 1 (2009)
institution	DOAJ
collection	DOAJ
language	EN
topic	orphan drugs exceptional drugs rare disease neglected disease legislation Food processing and manufacture TP368-456 Pharmaceutical industry HD9665-9675
spellingShingle	orphan drugs exceptional drugs rare disease neglected disease legislation Food processing and manufacture TP368-456 Pharmaceutical industry HD9665-9675 Gloria A. SANDOVAL Claudia P. VACCA G Jorge OLARTE VITAL MEDICINES NOT AVAILABLE: NATIONAL AND INTERNATIONAL REGULATION ANALYSIS, UPDATE PROPOSAL OF NATIONAL LIST
description	A comparative revision was carried out on the national and international policies and regulations about access of orphan and/or vital drugs.. An analysis of: orphan drugs´ list from USA, European Union and all applications for importation of not available drugs submitted by the Drug Regulatory Authority (INVIMA) until 2006; an informal consultation with health care providers, insurance companies and distributors of vital medicines, were included, in order to improve the actual vital drugs list within the frame of public health programs. The analysis included all drugs that have been protected by Decree 2085 from 2002, as well as the imported drugs by the Ministry of Social Welfare under the public health program. 26 of 107 proposed drugs match the lists of orphan drugs from the countries analyzed and 12 are protected with exclusivity by decree 2085 from 2002.
format	article
author	Gloria A. SANDOVAL Claudia P. VACCA G Jorge OLARTE
author_facet	Gloria A. SANDOVAL Claudia P. VACCA G Jorge OLARTE
author_sort	Gloria A. SANDOVAL
title	VITAL MEDICINES NOT AVAILABLE: NATIONAL AND INTERNATIONAL REGULATION ANALYSIS, UPDATE PROPOSAL OF NATIONAL LIST
title_short	VITAL MEDICINES NOT AVAILABLE: NATIONAL AND INTERNATIONAL REGULATION ANALYSIS, UPDATE PROPOSAL OF NATIONAL LIST
title_full	VITAL MEDICINES NOT AVAILABLE: NATIONAL AND INTERNATIONAL REGULATION ANALYSIS, UPDATE PROPOSAL OF NATIONAL LIST
title_fullStr	VITAL MEDICINES NOT AVAILABLE: NATIONAL AND INTERNATIONAL REGULATION ANALYSIS, UPDATE PROPOSAL OF NATIONAL LIST
title_full_unstemmed	VITAL MEDICINES NOT AVAILABLE: NATIONAL AND INTERNATIONAL REGULATION ANALYSIS, UPDATE PROPOSAL OF NATIONAL LIST
title_sort	vital medicines not available: national and international regulation analysis, update proposal of national list
publisher	Universidad de Antioquia
publishDate	2009
url	https://doaj.org/article/3a565dfc710f46d5a42c3ae53e1fd181
work_keys_str_mv	AT gloriaasandoval vitalmedicinesnotavailablenationalandinternationalregulationanalysisupdateproposalofnationallist AT claudiapvaccag vitalmedicinesnotavailablenationalandinternationalregulationanalysisupdateproposalofnationallist AT jorgeolarte vitalmedicinesnotavailablenationalandinternationalregulationanalysisupdateproposalofnationallist
_version_	1718420422056214528

VITAL MEDICINES NOT AVAILABLE: NATIONAL AND INTERNATIONAL REGULATION ANALYSIS, UPDATE PROPOSAL OF NATIONAL LIST

Ejemplares similares